Noble Molecules

PharmaceuticalsSeries ABoulder, USnoblemolecules.com

Latest round

Series A

Last raised

Aug 2006

Total raised

$0.5M

Investors

1

About Noble Molecules

Noble Molecules, Inc.Noble Molecules, Inc. is engaged in the development of specialized materials for various industries. The company is headquartered in Boulder, US.Noble Molecules specializes in the development and commercialization of advanced materials designed for a variety of industrial applications. Their core product offerings focus on specialty chemicals and innovative polymer solutions, which are engineered to meet high-performance standards in sectors such as aerospace, automotive, and electronics. The company aims to solve critical challenges including durability, weight reduction, and efficiency in material use, facilitating the adoption of these materials across numerous industries. Noble Molecules serves a diverse clientele, including manufacturers, product developers, and end-users in North America, Europe, and parts of Asia.Noble Molecules generates revenue through a structured model that primarily involves B2B transactions with manufacturers and industrial partners. The company engages in contractual agreements, where clients place orders for customized chemical solutions tailored to their specific operational needs. Transactions are structured around volume-based pricing, enabling clients to benefit from economies of scale while ensuring consistent supply. Pricing plans for their products are designed to reflect the quality and performance advantages they provide, particularly for their trademarked materials, which are positioned as premium offerings in the market. The company is targeting expansion into European and Asian markets by 2025, aiming to tap into increasing demand for sustainable industrial materials. This strategic move is aligned with their mission to address market needs while utilizing their advanced chemical solutions.

Who invested in Noble Molecules

1 investor across 1 round

See all investors in Noble Molecules

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Aug 3, 2006

    Amount

    $0.5M

    Investors

    Locked

Questions about Noble Molecules

Who invested in Noble Molecules?

Noble Molecules has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Noble Molecules raised?

Noble Molecules has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Noble Molecules last raise money?

Noble Molecules's most recent round on record is a Series A, in Aug 2006.

What does Noble Molecules do?

Noble Molecules is a pharmaceuticals company.

Where is Noble Molecules headquartered?

Noble Molecules is headquartered in Boulder, US.

Which VCs invest in companies like Noble Molecules?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Noble Molecules's stage. Their profiles are linked below.

Raising like Noble Molecules? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.